Meridian Diagnostics announced Tuesday it received FDAapproval of the third product in its line of Premier enzymeimmunoassays. The test identifies coccidiodomycosis, caused bythe fungus Coccidioides immitis . It causes flu-like symptoms,severe respiratory complications and sometimes death.
The Cincinnati company (NASDAQ:KITS) said the productreplaces the current treatment, which is more time consumingand less accurate. Meridian will begin to ship the product in thenext two weeks.
(c) 1997 American Health Consultants. All rights reserved.